André van Maurik

1.4k citations
38 papers · 956 · h-index 16

Impact in

  • Transplantation top 5%
    • Renal Transplantation Outcomes and Treatments
  • Immunology top 5%
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

  • Immunology 18
    • T-cell and B-cell Immunology 10
    • Immune Cell Function and Interaction 8
    • Immunotherapy and Immune Responses 7
  • Physiology 8
    • Salivary Gland Disorders and Functions 8
Co-authors
Kathryn J. Wood (11 shared papers)Nick D. Jones (11 shared papers)Peter J. Morris (7 shared papers)Masaki Hara (6 shared papers)Oliver Witzke (3 shared papers)Bernd M. Spriewald (3 shared papers)Clare Smith (1 shared paper)Cherry Kingsley (1 shared paper)
Journals
Annals of the Rheumatic Diseases (6 papers)Transplantation (5 papers)The Journal of Immunology (5 papers)Lara D. Veeken (2 papers)RMD Open (2 papers)
Partner nations
United KingdomUnited StatesNetherlands

In The Last Decade

André van Maurik

35 papers receiving 946 citations

Peers

André van Maurik
Comparison fields: 5 of 74
  • Transplantation 81
  • Immunology 480
  • Rheumatology 120
  • Genetics 115
  • Surgery 156
Replace Masaaki Toda with:
Masaaki Toda Japan
Marina Deschamps France
KI Welsh United Kingdom
M. J. Giphart Netherlands
Michel Y. Braun Belgium
Hoyong Lim United States
Sébastien Lemoine France
Allan Thiolat France
Rupert Kenefeck United Kingdom
Katherine Miles United Kingdom
André van Maurik relative to Masaaki Toda Japan Masaaki Toda's profile →
Citations per field
00.5×5×11.1×
Masaaki Toda · 1×
Citations per year

Countries citing papers authored by André van Maurik

Since Specialization
Citations

This map shows the geographic impact of André van Maurik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André van Maurik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André van Maurik more than expected).

Fields of papers citing papers by André van Maurik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André van Maurik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André van Maurik. The network helps show where André van Maurik may publish in the future.

Co-authors

The 25 scholars most cited alongside André van Maurik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with André van Maurik Line = papers co-authored together André van Maurik links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy
The Journal of Immunology ·André van Maurik, Manuela Herber, Kathryn J. Wood, Nick D. Jones
2002144
2
CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection
The Journal of Immunology ·Nick D. Jones, André van Maurik, Masaki Hara, Bernd M. Spriewald, Oliver Witzke, Peter J. Morris, Kathryn J. Wood
2000138
3
Differential Susceptibility of Heart, Skin, and Islet Allografts to T Cell-Mediated Rejection
The Journal of Immunology ·Nick D. Jones, Stuart E. Turvey, André van Maurik, Masaki Hara, Cherry Kingsley, Clare Smith, Andrew L. Mellor, Peter J. Morris, Kathryn J. Wood
2001137
4
10 Years of belimumab experience: What have we learnt?
Lupus ·Roger A. Levy, Tania Gonzalez‐Rivera, Munther A. Khamashta, Norma Lynn Fox, Angela R. Jones-Leone, Bernie Rubin, Susan W. Burriss, Kerry Gairy, André van Maurik, David A. Roth
202193
5
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome
JCI Insight ·Xavier Mariette, Francesca Barone, Chiara Baldini, Hendrika Bootsma, Kenneth L. Clark, Salvatore De Vita, David H. Gardner, Robert B. Henderson, Michael Herdman, Karoline Lerang, Prafull Mistry, Raj Punwaney, Raphaèle Séror, John H. Stone, Paul Van Daele, André van Maurik, Nicolas Wisniacki, David A. Roth, Paul P. Tak
202278
6
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes
Diabetologia ·Bart Keymeulen, André van Maurik, David R. Inman, João J. Oliveira, René McLaughlin, Rachel Gittelman, Bart O. Roep, Pieter Gillard, Robert Hilbrands, Frans Gorus, Chantal Mathieu, Ursule Van de Velde, Nicolas Wisniacki, Antonella Napolitano
202041
7
A CD3-Specific Antibody Reduces Cytokine Production and Alters Phosphoprotein Profiles in Intestinal Tissues From Patients With Inflammatory Bowel Disease
Gastroenterology ·Anna Vossenkämper, Christian Hundsrucker, Kevin Page, André van Maurik, Theodore J. Sanders, Andrew J. Stagg, Lisa Das, Thomas T. MacDonald
201428
8
INTRAGRAFT INTERLEUKIN-4 mRNA EXPRESSION AFTER SHORT-TERM CD154 BLOCKADE MAY TRIGGER DELAYED DEVELOPMENT OF TRANSPLANT ARTERIOSCLEROSIS IN THE ABSENCE OF CD8+ T CELLS1
Transplantation ·Stephan Ensminger, Bernd M. Spriewald, Oliver Witzke, Karen Morrison, André van Maurik, Peter J. Morris, Marlene L. Rose, Kathryn J. Wood
200026
9
T-Cell Activation, Proliferation, and Memory After Cardiac Transplantation In Vivo
Annals of Surgery ·Nick D. Jones, André van Maurik, Masaki Hara, Bryant J. Gilot, Peter J. Morris, Kathryn J. Wood
199925
10
Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model
Vaccine ·Nicolas Sabarth, M. Keith Howard, Helga Savidis-Dacho, André van Maurik, Perry Barrett, Otfried Kistner
200923
11
Epigenetically quantified immune cells in salivary glands of Sjögren’s syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopathology
Lara D. Veeken ·Sofie L. M. Blokland, Fréderique M van Vliet-Moret, Maarten R. Hillen, Aridaman Pandit, Roel Goldschmeding, Aike A. Kruize, Gerben Bouma, André van Maurik, Sven Olek, Ulrich Hoffmueller, Joël A. G. van Roon, Timothy R. D. J. Radstake
201921
12
VISUALIZATION OF THE IN VIVO GENERATION OF DONOR ANTIGEN-SPECIFIC EFFECTOR CD8+ T CELLS DURING MOUSE CARDIAC ALLOGRAFT REJECTION
Transplantation ·Bryant J. Gilot, Masaki Hara, Nick D. Jones, André van Maurik, Masanori Niimi, Vassilis G. Hadjianastassiou, Peter J. Morris, Kathryn J. Wood
200020
13
Induced CD8+FoxP3+ Treg Cells in Rheumatoid Arthritis Are Modulated by p38 Phosphorylation and Monocytes Expressing Membrane Tumor Necrosis Factor α and CD86
Arthritis & Rheumatology ·Shawn DP Ellis, Jenny L. McGovern, André van Maurik, David Howe, Michael R. Ehrenstein, Clare A. Notley
201418
14
Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination
Vaccine ·André van Maurik, Nicolas Sabarth, Helga Savidis Dacho, P Brühl, Michael G. Schwendinger, Brian A. Crowe, Perry Barrett, Otfried Kistner, M. Keith Howard
200916
15
Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity
RMD Open ·Maarten R. Hillen, Katia Urso, Emma Koppe, Ana P. Lopes, Sofie L. M. Blokland, Aridaman Pandit, Tom Slocombe, André van Maurik, Joël A. G. van Roon, Timothy R. D. J. Radstake
202016
16
Dependency of Direct Pathway CD4+ T Cells on CD40-CD154 Costimulation Is Determined by Nature and Microenvironment of Primary Contact with Alloantigen
The Journal of Immunology ·André van Maurik, Barbara Fazekas de St Groth, Kathryn J. Wood, Nick D. Jones
200415
17
Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway1
Transplantation ·André van Maurik, Kathryn J. Wood, Nick D. Jones
200215
18
A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
Trials ·Mark McClure, Seerapani Gopaluni, James Wason, Robert B. Henderson, André van Maurik, Caroline C.O. Savage, Charles D. Pusey, Alan D. Salama, Paul Lyons, Jacinta Lee, Kim Mynard, David Jayne, Rachel Jones, (unknown)
202313
19
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients
British Journal of Clinical Pharmacology ·Georgios Vlasakakis, Antonella Napolitano, Ruth M. Barnard, Kim Brown, Jonathan Bullman, David R. Inman, Bart Keymeulen, David Lanham, Quentin Leirens, Alexander MacDonald, Enrica Mezzalana, Kevin Page, Minesh Patel, Caroline O.S. Savage, Stefano Zamuner, André van Maurik
201812
20
Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination Strategies
Clinical and Vaccine Immunology ·Matthew G. Cottingham, André van Maurik, Manola Zago, Angela T. Newton, Richard J. Anderson, M. Keith Howard, Jörg Schneider, Michael A. Skinner
200612

About André van Maurik

André van Maurik is a scholar working on Immunology, Physiology, Rheumatology, Epidemiology and Surgery, having authored 38 papers that have together received 956 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (8 papers), Salivary Gland Disorders and Functions (8 papers), Immunotherapy and Immune Responses (7 papers), Systemic Lupus Erythematosus Research (6 papers), Diabetes and associated disorders (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). The work is most often cited by research in Transplantation (81 citations), Immunology (480 citations), Rheumatology (120 citations), Genetics (115 citations) and Surgery (156 citations). André van Maurik has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Kathryn J. Wood, Nick D. Jones, Peter J. Morris, Masaki Hara, Oliver Witzke, Bernd M. Spriewald, Clare Smith, Cherry Kingsley, Stuart E. Turvey and David A. Roth. Their work appears in journals such as Annals of the Rheumatic Diseases, Transplantation, The Journal of Immunology, Lara D. Veeken and RMD Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaaki TodaBreakdown of academic impact, for papers by Marina DeschampsBreakdown of academic impact, for papers by KI WelshBreakdown of academic impact, for papers by M. J. GiphartBreakdown of academic impact, for papers by Michel Y. BraunBreakdown of academic impact, for papers by Hoyong LimBreakdown of academic impact, for papers by Sébastien LemoineBreakdown of academic impact, for papers by Allan ThiolatBreakdown of academic impact, for papers by Rupert KenefeckBreakdown of academic impact, for papers by Katherine Miles